Which peptides are studied in relation to mucosal healing?
A research-supply catalogue summary of peptides and related compounds investigated in mucosal healing models, including GHK-Cu, teduglutide, zinc L-carnosine, and biomarker studies. For laboratory research use only.
Peptides studied in relation to mucosal healing include GHK-Cu (glycyl-L-histidyl-L-lysine copper), teduglutide, and zinc L-carnosine, among others. GHK-Cu is a copper-binding tripeptide with the sequence glycyl-L-histidyl-L-lysine; its copper complex is denoted GHK-Cu. Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue. Zinc L-carnosine is a chelate of zinc and L-carnosine. The evidence block does not provide molecular formulas, molecular weights, or full sequences for these compounds beyond the GHK-Cu tripeptide sequence. The work centres on the SIRT1/STAT3 signalling pathway for GHK-Cu, GLP-2 receptor family for teduglutide, and cytoprotective/anti-inflammatory pathways for zinc L-carnosine.
Mucosal healing is a recognised therapeutic endpoint in ulcerative colitis (UC), but its assessment in daily practice is limited by the low acceptability of repeated colonoscopies [3]. Fecal biomarkers such as calprotectin, chitinase 3-like 1 (CHI3L1), and matrix metalloprotease type 9 (MMP-9) are studied as alternatives [3]. In malnutrition enteropathy, a high pathogen burden damages the intestinal mucosa, leading to epithelial breaches, microbial translocation, and systemic inflammation [5].
Research Studies
GHK-Cu and DSS-induced murine colitis
GHK-Cu was evaluated in a dextran sulfate sodium (DSS)-induced murine model of UC, with emphasis on the SIRT1/STAT3 signalling pathway [1]. The study used BALB/c mice and aimed to systematically assess therapeutic potential and regulatory effects on SIRT1/STAT3 [1]. This evidence is animal-only.
Teduglutide and malnutrition enteropathy in children
The TAME study evaluates teduglutide, among other interventions, for malnutrition enteropathy in children with severe acute malnutrition [5]. Teduglutide is given for 14 days as part of a four-arm comparison against standard care [5]. This is a clinical trial in a paediatric population.
Zinc L-carnosine and oral mucosal injury
A systematic review and meta-analysis assessed zinc L-carnosine for protective and healing effects on the oral mucosa [6]. Zinc L-carnosine is described as cytoprotective with anti-inflammatory, antioxidant, and epithelial reparative properties [6]. This evidence is from a systematic review and meta-analysis; it is reference-only and supports the page rather than forming its core.
Lactobacillus probiotics and trace elements in UC maintenance
An interventional observational study evaluates lactobacillus probiotics or trace elements added to infliximab for maintaining remission in UC patients [2]. The study compares adding lactobacillus probiotics versus adding trace elements to infliximab in an open-label, parallel, prospective design [2]. This is a clinical study in UC patients.
Fecal and serum biomarkers for predicting mucosal healing in UC
A study examines variation in serum and fecal biomarkers after treatment to predict mucosal healing in UC patients [3]. Fecal calprotectin shows very good negative predictive value to eliminate IBD diagnosis, good correlation to endoscopic activity, and good ability to predict relapse [3]. Fecal CHI3L1, MMP-9, and serum NGAL-MMP9 and CHI3L1 are studied as potentially better biomarkers [3]. This is a clinical study in UC patients.
Gene expression and mitochondrial function in IBD ulcer healing
A study compares non-healing colonic ulcers in IBD patients with iatrogenic colonic ulcers in healthy controls and patients with rheumatoid or psoriatic arthritis [4]. Biopsies are taken at baseline and follow-up in a "biopsy of the biopsy" approach to reveal patterns in gene expression and mitochondrial function during ulcer healing [4]. This is a clinical study in IBD patients and controls.
Colostrum, N-acetyl glucosamine, and budesonide in malnutrition enteropathy
The TAME study also evaluates colostrum, N-acetyl glucosamine, and budesonide for malnutrition enteropathy in children with severe acute malnutrition [5]. These interventions are given for 14 days and compared against standard care [5]. This is a clinical trial in a paediatric population.
Comparison of studied compounds and models
| Compound | Model/Population | Mechanism/Pathway | Evidence type |
|---|---|---|---|
| GHK-Cu | DSS-induced murine colitis | SIRT1/STAT3 | Animal [1] |
| Teduglutide | Children with severe acute malnutrition | GLP-2 analogue | Clinical trial [5] |
| Zinc L-carnosine | Oral mucosa | Cytoprotective, anti-inflammatory, antioxidant, epithelial reparative | Systematic review/meta-analysis [6] |
| Lactobacillus probiotics | UC patients on infliximab | Not specified in evidence | Clinical study [2] |
| Trace elements | UC patients on infliximab | Not specified in evidence | Clinical study [2] |
| Colostrum | Children with severe acute malnutrition | Not specified in evidence | Clinical trial [5] |
| N-acetyl glucosamine | Children with severe acute malnutrition | Not specified in evidence | Clinical trial [5] |
| Budesonide | Children with severe acute malnutrition | Not specified in evidence | Clinical trial [5] |
If you are reading this for personal health reasons
This material is sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
- [2] The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients
- [3] Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis
- [4] Regulation of Mucosal Healing in Inflammatory Bowel Disease
- [5] Therapeutic Approaches to Malnutrition Enteropathy
- [6] Protective and Healing Effects of Zinc L-Carnosine on the Oral Mucosa: A Systematic Review and Meta-Analysis